Jun 17, 3:17 AM EDT
Rigel to roll out Veppanu in August; Arvinas, Pfizer snag $70M upfront on cleared deal
ARVNPFE
Morsa Images Rigel Pharmaceuticals ( RIGL ) has cleared the final regulatory hurdle to secure the global rights for the breast cancer drug Veppanu , cutting a $70M upfront check to partners Arvinas ( ARVN ) and Pfizer ( PFE ) after receiving early Hart-Scott-R…